Xi'An International Medical Investment News

International Medicine (000516) 2023 Report and 2024 Quarterly Report Review: Operation has reached a new level and a full-life cycle healthcare platform has initially taken shape

華創證券May 17 07:16

International Medicine (000516): The overall operation loss situation of large general medical hospitals is gradually improving

國盛證券May 15 16:16

International Medicine (000516): Continued expansion of business scale and gradual improvement of profitability

東吳證券May 10 07:11

International Medicine (000516): Continued improvement in performance is expected to accelerate the reversal of losses throughout the year

東北證券May 6 00:00

International Medicine (000516) Company Brief Review Report: Continued expansion of business scale is expected to accelerate profitability

東海證券Apr 29 00:00

International Medicine (000516): Performance is in line with expectations and continues to accumulate strength

西南證券Apr 28 00:00

International Medicine (000516) In-depth Research Report: The time is right for a regional comprehensive medical service leader to take off

華創證券Apr 12 07:26

International Medicine (000516): High revenue growth in 2023Q4, steady profits, and 2024 is expected to usher in a profit inflection point

中郵證券Feb 2 00:00

International Medicine (000516): Operating losses narrowed month-on-month in the fourth quarter, revenue climbed and business trends improved in 23 years

東吳證券Jan 31 14:41

International Medicine (000516): In 4Q23, revenue increased again in a single quarter, and the volume of inpatient services continued to increase

國金證券Jan 30 00:00

International Medicine (000516): Continued optimization of asset structure may usher in a loss-turning point

興業證券Nov 14, 2023 18:46

Research Report Nuggets: Southwest Securities: Maintaining the International Medical “Buy” Rating, Target Price: 13.29 Yuan

Gelonghui FinanceNov 6, 2023 15:49

International Medicine (000516): Revenue fell slightly month-on-month, profit side and cash flow improved

東吳證券Oct 30, 2023 15:46

International Medicine (000516): Revenue increased 80% year on year and is expected to achieve profit in a single month

國金證券Oct 28, 2023 00:00

International Medicine (000516) Company Brief Review Report: Revenue Structure Continues to Optimize, Profit Side Accelerates Improvement

東海證券Oct 27, 2023 00:00

International Medicine (000516): Losses continue to narrow and there is broad room for long-term growth

華安證券Sep 20, 2023 00:00

International Medicine (000516) Company Information Update Report: Revenue Hits Record High in a Single Quarter, and Hospital Profitability Continues to Increase

開源證券Aug 28, 2023 16:16

International Medicine (000516): Special specialties that are scarce in general hospitals can be expected in the future

東吳證券(國際)Aug 28, 2023 00:00

International Medicine (000516): The number of medical treatments is rising season by quarter, and business is improving steadily

東海證券Aug 28, 2023 00:00

International Medicine (000516) 2023 Interim Report Review: Revenue Side Has Increased Significantly and the Construction of Advantageous Disciplines Continues to Advance

中信證券Aug 28, 2023 00:00